These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Depression by antiparkinson drugs of reserpine rigidity. Jurna I. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1968 May 07; 260(1):80-8. PubMed ID: 4236376 [No Abstract] [Full Text] [Related]
3. Inhibition of the effect of reserpine on motor control by drugs which influence reserpine rigidity. Jurna I, Lanzer G. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1969 May 07; 262(3):309-24. PubMed ID: 4238719 [No Abstract] [Full Text] [Related]
4. The effect of physostigmine and tetrabenazine on spinal motor control and its inhibition by drugs which influence reserpine rigidity. Jurna I, Theres C, Bachmann T. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1969 May 07; 263(3):427-38. PubMed ID: 4239718 [No Abstract] [Full Text] [Related]
6. Influence of anticholinergic-antiparkinsonian agents on the effects of narcoanalgesic drugs in the rat. Fischer E, Heller B, Lumbreras N. Experientia; 1973 Feb 15; 29(2):188-9. PubMed ID: 4144250 [No Abstract] [Full Text] [Related]
7. Flurothyl in mice: seizure, post-convulsive behavior, and interactions with psychotropic drugs. Boissier JR, Simon P, Villeneuve A, Larousse C. Can J Physiol Pharmacol; 1968 Jan 15; 46(1):93-100. PubMed ID: 4384460 [No Abstract] [Full Text] [Related]
11. The mechanism of action of anticonvulsants. II. Acetazolamide. Rudzik AD, Mennear JH. Life Sci; 1966 Apr 15; 5(8):747-56. PubMed ID: 5961371 [No Abstract] [Full Text] [Related]
12. [Interference of the central antichloinergic effect in experimental animal tests of potential antidepressives]. Schaumann W, Ribbentrop A. Arzneimittelforschung; 1966 May 15; 16(5):646-9. PubMed ID: 6014433 [No Abstract] [Full Text] [Related]
13. Motor disturbance induced by tremorine and oxotremorine. Jurna I, Nell T, Schreyer I. Naunyn Schmiedebergs Arch Pharmakol; 1970 May 15; 267(1):80-98. PubMed ID: 4393397 [No Abstract] [Full Text] [Related]
14. Antiparkinsonian drugs and central dopamine neurons. Fuxe K, Goldstein M, Ljungdahl A. Life Sci I; 1970 Jul 15; 9(14):811-24. PubMed ID: 5478392 [No Abstract] [Full Text] [Related]
15. Interaction between phenylalkylamine derivatives and reserpine. Vizi ES, Knoll B, Knoll J. Int J Neuropharmacol; 1968 Nov 15; 7(6):503-9. PubMed ID: 5712879 [No Abstract] [Full Text] [Related]
16. Interaction of anticholinergic agents with -methyl-p-tyrosine and (+)-amphetamine. Sayers AC. Br J Pharmacol; 1972 May 15; 45(1):170P-171P. PubMed ID: 5064932 [No Abstract] [Full Text] [Related]
17. A neuronal basis for the alerting action of (+)-amphetamine. Boakes RJ, Bradley PB, Candy JM. Br J Pharmacol; 1972 Jul 15; 45(3):391-403. PubMed ID: 5072225 [Abstract] [Full Text] [Related]
18. An evaluation of the vasodilation produced by mephentermine and certain other sympathomimetic amines. Caldwell RW, Goldberg LI. J Pharmacol Exp Ther; 1970 Apr 15; 172(2):297-309. PubMed ID: 4392532 [No Abstract] [Full Text] [Related]
19. BEHAVIORAL EFFECTS OF INTERACTING IMIPRAMINE AND OTHER DRUGS WITH D-AMPHETAMINE, COCAINE, AND TETRABENAZINE. SCHECKEL CL, BOFF E. Psychopharmacologia; 1964 Feb 12; 5():198-208. PubMed ID: 14138755 [No Abstract] [Full Text] [Related]
20. The pharmacological properties of melitracen (N 7001) and litracen (N 7049). Nielsen IM, Nymark M, Hougs W, Pedersen V. Arzneimittelforschung; 1966 Feb 12; 16(2):135-40. PubMed ID: 6014004 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]